We have read and reviewed the report on observational research, published Oct. 10 in the Journal of the American Heart Association, which concludes that taking calcium in the form of supplements may raise the risk of atherosclerosis as assessed by calcium deposits in the coronary arteries, although a diet high in calcium-rich foods appears to… Read more »
Osteoporosis in the News
Fracture-Liaison Service Greatly Improves Postfracture Care »
ATLANTA ā The dismal rate at which treatment of osteoporosis is initiated following any fragility fracture in the United States can be dramatically improved with the help of a fracture-liaison service, a demonstration project indicates. “All three sites, including Georgetown University Hospital, where I am, and the University of Pittsburgh Medical Center and Creighton Health… Read more »
Clinical Trial Results Released For ACTIVE Study »
In its August 16, 2016 issue of The Journal of the American Medical Association (JAMA), the phase 3 results of the Abaloparatide Comparator Trial In Vertebral Endpoints (ACTIVE) trial were released. Read this article here! An accompanying editorial can be found here.
CMS Proposes New Fee Schedules for 2017 »
On July 14, 2016, the Centers for Medicare and Medicaid Services (CMS) published the proposed rule for the Hospital Outpatient Prospective Payment SystemĀ (HOPPS) for 2017. CMS has proposed to cut the reimbursement rate for Axial DXA, CPT 77080 in the hospital setting from the current national average of $100.69 to $63.33.Ā This reimbursement cut will… Read more »
Fearing Drugsā Rare Side Effects, Millions Take Their Chances With Osteoporosis »
Millions of Americans are missing out on a chance to avoid debilitating fractures from weakened bones, researchers say, because they are terrified of exceedingly rare side effects from drugs that can help them.Ā Last month, the American Society for Bone and Mineral Research, the National Osteoporosis Foundation and the National Bone Health Alliance put out… Read more »
Clinical Trial by Juvent Confirms New Device Improves Bone Density in Cancer Survivors »
One our Corporate Advisory Roundtable members, Juvent, announced very positive results from the St. Jude Childrenās Hospital Clinical Trial. An 11% increase in bone density was seen in childhood cancer survivors through their product,Ā JuventĀ® Dynamic Motion Therapy Platform. The study was published in the Journal of the American Medical Association (JAMA) Oncology. To learn more,… Read more »
Medicare Nation Interviews from the Interdisciplinary Symposium on Osteoporosis (ISO16) »
NOF is pleased to share interviews recorded by the Medicare Nation podcast, media partner for NOFās annual conference, the Interdisciplinary Symposium on Osteoporosis, held May 12-15, 2016 in Miami, FL. Medicare Nation is a weekly podcast dedicated to bringing listeners everything they need to know about Medicare but are afraid to ask. They feature interviews… Read more »
Statement from ASBMR, NOF, and NBHA on Treating Osteoporosis »
The Nation’s leading scientific and medical bone health experts call for action on the dangers of not treating osteoporosis more aggressively. They are urging healthcare professionals to increase diagnosis and patients to be aware of this risk. Read statements released by leading organizations in the fieldĀ in this PRNewswire article.
NIH Research Matters: Bone Risks Linked to Genetic Variants »
The results of this large scale genomic study provide insights into the genetics underlying osteoporosis and may lead to new ways to prevent bone loss and fractures. Read more about the bone risks linked to genetic variants.
Overdiagnosis of Osteoporosis: Fact or Fallacy? »
An Editorial Published in Osteoporosis International Responds to the BMJ Article Claiming an Overdiagnosis of Osteoporosis An editorial published this week in Osteoporosis International responds to the recent British Medical Journal (BMJ) article that claimed osteoporosis is overdiagnosed. The editorial, authored by Professor Juliet Compston, Chair of the National Osteoporosis Guideline Group and IOF EU… Read more »